5th Rx-to-OTC Switch Summit

Memo

Switching drugs from prescription (Rx) to over-the-counter (OTC) status is a commercial strategy that has been growing in popularity. Successful switches are as much an art as a science, and it has become increasingly apparent that switch teams must revise their best practices in strategy, marketing, sales, clinical research, regulatory affairs, medical writing, labeling, and packaging if they are to effectively collaborate and lead an Rx product through the switch to OTC. Now in its fifth consecutive year, ExL’s Rx-to-OTC Switch Summit is the most advanced thought leadership event experts can attend to discuss all aspects of a switch, from the NDA process to the final over-the-counter product; analyze current trends, and prepare for future switches. Whether you are exploring your chances of tapping into the very lucrative OTC marketplace or are an expert in the field, this conference will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests. Prices:Early Bird Pricing — Register by October 26, 2018: USD 1895.0,Standard Pricing: USD 2095.0,Onsite Pricing: USD 2295.0 Time: 8:00 am - 4:00 pm Venue details: Sonesta Philadelphia Downtown Rittenhouse Square,1800 Market St,19103,Philadelphia, USA